These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 19366380)

  • 1. Depression, quality of life, and glycemic control in individuals with type 2 diabetes.
    Lee HJ; Chapa D; Kao CW; Jones D; Kapustin J; Smith J; Krichten C; Donner T; Thomas SA; Friedmann E
    J Am Acad Nurse Pract; 2009 Apr; 21(4):214-24. PubMed ID: 19366380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of depression among people with type 2 diabetes mellitus: a cross sectional study in Palestine.
    Sweileh WM; Abu-Hadeed HM; Al-Jabi SW; Zyoud SH
    BMC Public Health; 2014 Feb; 14():163. PubMed ID: 24524353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening and correlates of depression and HbA1 C in United Arab Emirates (UAE) women with diabetes.
    Hawamdeh S; Almakhzoomy I; Hayajneh Y
    Perspect Psychiatr Care; 2013 Oct; 49(4):262-8. PubMed ID: 25187447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes in primary care: prospective associations between depression, nonadherence and glycemic control.
    Dirmaier J; Watzke B; Koch U; Schulz H; Lehnert H; Pieper L; Wittchen HU
    Psychother Psychosom; 2010; 79(3):172-8. PubMed ID: 20234147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between depression with glycemic control and its complications in type 2 diabetes.
    Mansori K; Shiravand N; Shadmani FK; Moradi Y; Allahmoradi M; Ranjbaran M; Ahmadi S; Farahani A; Samii K; Valipour M
    Diabetes Metab Syndr; 2019; 13(2):1555-1560. PubMed ID: 31336521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interplay between diabetes, depression and affective temperaments: A structural equation model.
    Belvederi Murri M; Mamberto S; Briatore L; Mazzucchelli C; Amore M; Cordera R
    J Affect Disord; 2017 Sep; 219():64-71. PubMed ID: 28525822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medication Management Program: Adherence, Disease-related Knowledge, Health-related Quality of Life, and Glycemic Control for Type 2 Diabetes Mellitus.
    Nazir SUR; Hassali MA; Saleem F; Haque N
    Altern Ther Health Med; 2020 Jul; 26(S2):4-10. PubMed ID: 31634877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychological distress, self-efficacy and glycemic control in type 2 diabetes.
    Indelicato L; Dauriz M; Santi L; Bonora F; Negri C; Cacciatori V; Targher G; Trento M; Bonora E
    Nutr Metab Cardiovasc Dis; 2017 Apr; 27(4):300-306. PubMed ID: 28274728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How Much Do We Know about the Biopsychosocial Predictors of Glycaemic Control? Age and Clinical Factors Predict Glycaemic Control, but Psychological Factors Do Not.
    Abdullah MFILB; Sidi H; Ravindran A; Gosse PJ; Kaunismaa ES; Mainland RL; Mustafa N; Hatta NH; Arnawati P; Zulkifli AY; Woon LS
    J Diabetes Res; 2020; 2020():2654208. PubMed ID: 32455131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depression in Tunisian type 2 diabetic patients: prevalence and association to glycemic control and to treatment compliance.
    Ellouze F; Damak R; El Karoui M; Mami H; M'rad MF; Hamdi G; Abid A
    Tunis Med; 2017 Mar; 95(3):210-214. PubMed ID: 29446817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes knowledge, medication adherence and glycemic control among patients with type 2 diabetes.
    Al-Qazaz HKh; Sulaiman SA; Hassali MA; Shafie AA; Sundram S; Al-Nuri R; Saleem F
    Int J Clin Pharm; 2011 Dec; 33(6):1028-35. PubMed ID: 22083724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between diabetes self-care, medication adherence, anxiety, depression, and glycemic control in type 2 diabetes.
    Al-Hayek AA; Robert AA; Alzaid AA; Nusair HM; Zbaidi NS; Al-Eithan MH; Sam AE
    Saudi Med J; 2012 Jun; 33(6):681-3. PubMed ID: 22729127
    [No Abstract]   [Full Text] [Related]  

  • 13. Factors Associated with Poor Hemoglobin A1c Control in Patients with Type 2 Diabetes.
    Alqudah S; Jarab AS; Alefishat EA; Mayyas F; Khdour M; Pinto S
    Curr Diabetes Rev; 2019; 15(2):164-170. PubMed ID: 29745337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of depression with treatment outcomes in Type 2 Diabetes Mellitus: a cross-sectional study from Karachi, Pakistan.
    Zuberi SI; Syed EU; Bhatti JA
    BMC Psychiatry; 2011 Feb; 11():27. PubMed ID: 21324127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of hospital-diagnosed depression or use of antidepressants on treatment initiation, adherence and HbA
    Rohde C; Knudsen JS; Schmitz N; Østergaard SD; Thomsen RW
    Diabetologia; 2021 Feb; 64(2):361-374. PubMed ID: 33073329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease related knowledge, medication adherence and glycaemic control among patients with type 2 diabetes mellitus in Pakistan.
    Nazir SU; Hassali MA; Saleem F; Bashir S; Aljadhey H
    Prim Care Diabetes; 2016 Apr; 10(2):136-41. PubMed ID: 26476867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psycho-social and clinical variables associated with depression in patients with type 2 diabetes.
    Stanković Z; Jašović-Gašić M; Zamaklar M
    Psychiatr Danub; 2011 Mar; 23(1):34-44. PubMed ID: 21448095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Distress Reduction on Behavioral Correlates and A1C in African American Women with Uncontrolled Type 2 Diabetes: Results from EMPOWER.
    Cummings DM; Lutes LD; Littlewood K; Solar C; Hambidge B; Gatlin P
    Ethn Dis; 2017; 27(2):155-160. PubMed ID: 28439186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonadherence to insulin therapy in low-income, type 2 diabetic patients.
    Lerman I; Díaz JP; Ibarguengoitia ME; Pérez FJ; Villa AR; Velasco ML; Cruz RG; Rodrigo JA
    Endocr Pract; 2009; 15(1):41-6. PubMed ID: 19211396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors influencing glycemic control in type 2 diabetes during acute- and maintenance-phase treatment of major depressive disorder with bupropion.
    Lustman PJ; Williams MM; Sayuk GS; Nix BD; Clouse RE
    Diabetes Care; 2007 Mar; 30(3):459-66. PubMed ID: 17327305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.